Turner Investments’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Turner Investments’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,000	Closed	-$249K	–	310
2016 Q4	$249K	Buy	+20,000	New	+$241K	0.1%	216
2015 Q3	–	Sell	-225,090	Closed	-$1.86M	–	322
2015 Q2	$1.86M	Buy	225,090 +149,370	+197%	+$1.32M	0.34%	98
2015 Q1	$624K	Buy	+75,720	New	+$560K	0.11%	206

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Turner Investments's ARIA Position: Q1 2017 in Review

Turner Investments sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 20,000 shares — an estimated $249K sold.

Turner Investments first reported a position in ARIA in Q1 2015 and held it in 3 quarters. The position peaked at $1.86M in Q2 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Turner Investments reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Turner Investments sold 20,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $249K.
Turner Investments first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 3 quarters.
Turner Investments's Ariad Pharmaceuticals Inc position peaked at $1.86M in Q2 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.